Kodera E, Fujiwara M, Ito Y, Ohashi N, Nakayama G, Koike M, Nakao A
Department of Surgery II, Nagoya University School of Medicine, Showa, Nagoya, Aichi, Japan.
Acta Chir Belg. 2009 Jan-Feb;109(1):27-35. doi: 10.1080/00015458.2009.11680367.
In the current review article, evidences on radical surgery for gastric cancer reported in the literature are highlighted. The authors conclude that extended lymphadenectomy offers a statistically significant survival benefit. This benefit is only evident if the operative mortality is less than 2%, as obtained in centers of excellence with a high-volume experience of resection of gastric cancer. Lymphadenectomy should no longer be considered only as a tool for cancer-staging, but also as a beneficial therapeutic measure.